Influenza, Human: all 2,265 studies
Page 11 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.
- SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)CompletedNCT05765396
- A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy AdultsCompletedNCT05755620Phase 1
- Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.CompletedNCT05734040Phase 2
- Project STARFISH - PRJ0002679CompletedNCT05727202
- Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in ChinaCompletedNCT05720091Phase 1
- Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test DeviceCompletedNCT05715515Not applicable
- Nosocomial Influenza Surveillance of 2022 - 2027 Seasonal PeriodWithdrawnNCT05712759
- Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy SubjectsCompletedNCT05711797Phase 1
- Plant Stanol Esters and Influenza VaccinationCompletedNCT05706350Not applicable
- A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated InfluenzaCompletedNCT05702489Phase 2/3
- Probiotics and Influenza Vaccination ResponseCompletedNCT05690373Not applicable
- Seasonal Influenza and Pneumococcal Vaccination in the ElderlyCompletedNCT05661890
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and OlderCompletedNCT05650554Phase 1/2
- A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 MonthsCompletedNCT05645900Phase 3
- Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split VaccineCompletedNCT05642078Phase 3
- Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal SwabsCompletedNCT05630365Not applicable
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and OlderCompletedNCT05624606Phase 1/2
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy AdultsCompletedNCT05606965Phase 2
- GRIP: Maximum Isometric Grip Strength Assessed with Three Different Hand-held DynamometersCompletedNCT05594888
- A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years OldCompletedNCT05585632Phase 1
- Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in AdultsStatus unknownNCT05582239
- Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza VaccinCompletedNCT05581407Phase 1
- Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainCompletedNCT05572450Not applicable
- Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μgCompletedNCT05569239Phase 2
- Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23CompletedNCT05568979
- Impact of High Dietary Fiber on Microbiome and Vaccine ResponsesActive, not recruitingNCT05565586Not applicable
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and OlderCompletedNCT05553301Phase 1/2
- A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory InfectionsCompletedNCT05544916Phase 3
- Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine UptakeCompletedNCT05542004Not applicable
- Influenza Vaccine Uptake Among Healthcare WorkersStatus unknownNCT05521763Not applicable
- A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineCompletedNCT05519839Phase 2
- A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older AdultsActive, not recruitingNCT05518500Phase 4
- A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older AdultsCompletedNCT05517174Phase 4
- Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), InactivatedCompletedNCT05512494Phase 4
- Flu Shot Pre-visit QuestionnaireCompletedNCT05508698Not applicable
- Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in ChileStatus unknownNCT05494047Phase 3
- Immunogenicity Trial of 3 Influenza VaccinesCompletedNCT05479370Phase 3
- To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus InfectionCompletedNCT05474755Phase 3
- Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide VaccineCompletedNCT05471531Phase 4
- Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years OldCompletedNCT05470582Phase 3
- Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant WomenCompletedNCT05457894Phase 3
- Spirulina Oral Supplement for Enhancing Host Resilience to Virus InfectionCompletedNCT05447078Phase 3
- Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge ModelCompletedNCT05436444Phase 1
- Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in InfantsActive, not recruitingNCT05436184
- Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, QuadrivalentCompletedNCT05431725Phase 3
- Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and OlderCompletedNCT05426174Phase 1
- Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult PatientsCompletedNCT05409612Phase 3
- Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and AboveCompletedNCT05406180
- Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type bCompletedNCT05401305Phase 1
- A Study of Modified mRNA Vaccines in Healthy AdultsCompletedNCT05397223Phase 1
- To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 YearsStatus unknownNCT05389137Phase 4
- Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in ChildrenCompletedNCT05378022Not applicable
- Early Oseltamivir Carboxylate Low Plasma Concentration in Patients Admitted to Intensive Care for Severe InfluenzaStatus unknownNCT05375864Not applicable
- Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant CultureStatus unknownNCT05375006
- Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.CompletedNCT05354115Not applicable
- Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other EthiologiesCompletedNCT05353725
- The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.CompletedNCT05317767Phase 3
- Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive ChildrenStatus unknownNCT05315024Not applicable
- A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 YearsCompletedNCT05313893Phase 4
- Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 YearsCompletedNCT05312294Phase 3
- Tolerability, Safety and Immunogenicity Trial of the FLU-M® TetraCompletedNCT05308212Phase 2/3
- Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23Status unknownNCT05298800Phase 4
- Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBACompletedNCT05297994Phase 2
- Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.CompletedNCT05284799Phase 2
- Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South AfricaStatus unknownNCT05277298
- Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral InfectionCompletedNCT05273619Phase 3
- Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral InfectionCompletedNCT05269329Phase 2
- Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral InfectionsCompletedNCT05269290Phase 3
- INNA-051 Influenza Challenge StudyCompletedNCT05255822Phase 2
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy AdultsCompletedNCT05252338Phase 1
- A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 MonthsCompletedNCT05245552Phase 3
- Association Between Gut Microbiome and Dietary Determinants and Vaccine ResponseActive, not recruitingNCT05239403
- Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and CaregiversCompletedNCT05234229
- Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart FailureStatus unknownNCT05232292Phase 4
- A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of InfluenzaCompletedNCT05227001Phase 1
- Intramuscular CodaVax-H1N1 in Healthy AdultsCompletedNCT05223179Phase 1
- Effectiveness of SMS Reminders on Influenza Vaccination Coverage in Patients With RA in the ART RegistryCompletedNCT05220423Not applicable
- High vs. Standard Dose Influenza Vaccine in Lung Allograft RecipientsActive, not recruitingNCT05215327Phase 2
- A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 MonthsCompletedNCT05212623Phase 1
- Taxifolin/Ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr)Active, not recruitingNCT05190432Not applicable
- A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.CompletedNCT05184387
- Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older AdultsCompletedNCT05163847Phase 1
- Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid PanelCompletedNCT05163730Not applicable
- A Study to Look at the Health Outcomes of Patients With COVID-19 and InfluenzaActive, not recruitingNCT05160636
- Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza VaccinationCompletedNCT05157425Not applicable
- Universal Influenza A Vaccine in Healthy AdultsCompletedNCT05155319Phase 1
- A Randomized Controlled Trial Evaluating an Online Intervention in Increasing Seasonal Influenza Vaccination Among Community Dwelling People Aged ≥65 YearsCompletedNCT05155241Not applicable
- Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene ExpressionCompletedNCT05154383Phase 4
- The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy VolunteersCompletedNCT05152017Phase 1
- A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 YearsStatus unknownNCT05144464Phase 4
- Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 YearsCompletedNCT05138705Phase 4
- Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)Active, not recruitingNCT05129436
- The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 YearsCompletedNCT05126979Phase 1
- Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.TerminatedNCT05116917Phase 2
- Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and ProtectionActive, not recruitingNCT05110911
- Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency RoomTerminatedNCT05105191Not applicable
- Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With InfluenzaCompletedNCT05095545Phase 2
- Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated InfluenzaStatus unknownNCT05093998Phase 3
- The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years OldCompletedNCT05089123Phase 3
- Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021CompletedNCT05087355